Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
OwnerDavid M. Kurnitinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerDavid M. Kurnitinventor
Estimating the term…
The invention comprises novel compositions, systems, and methods for the analysis of biological samples, such as urine samples, in order to diagnose and treat kidney disease, including without limitation, glomerulonephritis, nephrotic syndrome, diabetes, lupus, hypertension, acute tubular necrosis, obstructive disorders of the urinary tract, renal cancers and other diseases or syndromes. In preferred embodiments, the invention comprises the identification of particular genes expressed only in cells of particular clinical or scientific interest in the urinary tract, such as podocytes or proximal tubule cells. Thus, the invention enables non-invasive, rapid and accurate analysis of kidney and urinary tract status and function in many medical diseases and disorders.
A method for detecting kidney disease, comprising the step of:
A method of assessing the presence of podocytes in a mammalian urine sample, comprising the steps of:
A method of assessing the presence of podocytes in a mammalian urine sample, comprising the steps of:
A method of assessing the presence of podocytes in a mammalian urine sample, comprising the steps of:
A method of assessing the presence of podocytes in a human urine sample, comprising the steps of:
A method of assessing the presence of proximal tubule cells in a mammalian urine sample, comprising the steps of:
A method of assessing the presence of proximal tubule cells in a mammalian urine sample, comprising the steps of:
A method of assessing the presence of proximal tubule cells in a mammalian urine sample, comprising the steps of:
A method of assessing the presence of proximal tubule cells in a human urine sample, comprising the steps of:
A method of diagnosing, and monitoring the course of, mammalian kidney disease, comprising the steps of:
A method of diagnosing, and monitoring the course of, mammalian kidney disease, comprising the steps of:
A method of diagnosing, and monitoring the course of, mammalian kidney disease, comprising the steps of:
A method of diagnosing, and monitoring the course of, human kidney disease, comprising the steps of:
A method of diagnosing, and monitoring the course of, mammalian kidney disease, comprising the steps of:
A method of diagnosing, and monitoring the course of, mammalian kidney disease, comprising the steps of:
A method of diagnosing, and monitoring the course of, mammalian kidney disease, comprising the steps of:
A method of diagnosing, and monitoring the course of, human kidney disease, comprising the steps of:
A primer for assessing the level of expression of the podocyte gene for human nephrin by reverse transcriptase quantitative polymerase chain reaction assay, comprised of SEQ ID NO:
A primer for assessing the level of expression of the podocyte gene for human nephrin by reverse transcriptase quantitative polymerase chain reaction assay, comprised of SEQ ID NO:
A probe for assessing the level of expression of the podocyte gene for human nephrin by reverse transcriptase quantitative polymerase chain reaction assay, comprised of SEQ ID NO:
A primer for assessing the level of expression of the proximal tubule cell gene for human Indian hedgehog by reverse transcriptase quantitative polymerase chain reaction assay, comprised of SEQ ID NO:
A primer for assessing the level of expression of the proximal tubule cell gene for human Indian hedgehog by reverse transcriptase quantitative polymerase chain reaction assay, comprised of SEQ ID NO:
A probe for assessing the level of expression of the proximal tubule cell gene for human Indian hedgehog by reverse transcriptase quantitative polymerase chain reaction assay, comprised of SEQ ID NO:
A primer for assessing the level of expression of the gene for human β-actin by reverse transcriptase quantitative polymerase chain reaction assay, comprised of SEQ ID NO:
A primer for assessing the level of expression of the gene for human β-actin by reverse transcriptase quantitative polymerase chain reaction assay, comprised of SEQ ID NO:
A probe for assessing the level of expression of the gene for human β-actin by reverse transcriptase quantitative polymerase chain reaction assay, comprised of SEQ ID NO:
Dependencies are inferred from the claim text.